Search tips
Search criteria 


Logo of bmjcrBMJ Case ReportsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
BMJ Case Rep. 2015; 2015: bcr2014208812.
Published online 2015 March 20. doi:  10.1136/bcr-2014-208812
PMCID: PMC4369054

CT findings in Fahr's disease


A 65-year-old man presented to our services with features of dementia and movement disorder for 2 years. The symptoms had worsened over the past month with development of auditory hallucinations. CT demonstrated extensive calcification in bilateral basal ganglia, grey–white matter junctions and dentate nuclei. Serum calcium, phosphate and parathormone levels were normal. Fahr's disease was diagnosed based on the clinical and imaging findings.

Fahr's disease is an autosomal dominant inherited disorder characterised by basal ganglia and extraganglionic calcification, extrapyramidal symptoms and psychosis.1 Usual age of presentation is 40–60 years with no gender predilection.1 Psychosis is proportionate to degree of calcification and cerebral atrophy. Calcification typically occurs in the lateral part of the globus pallidus, dentate nuclei and caudate nuclei.1 2 Other sites include grey–white matter junction, white matter tracts and thalami (figure 1). However, the sites of calcification are not specific and a similar pattern may be found in hypoparathyroidism, pseudohypoparathyroidism and hyperparathyroidism.2 Normal calcium, phosphate and parathormone levels in Fahr's disease aid in diagnosis.1 2 Other differentials include senescent calcification (punctate, less extensive, occurring in the medial globus pallidus), HIV encephalopathy (cerebral atrophy, low CD4 counts), Cockayne syndrome (dwarfism, microcephaly, mental retardation, cerebral atrophy), and as sequelae to intrathecal chemotherapy and radiotherapy to the skull.2

Figure 1
Fahr’s disease (Striopallidodentate calcinosis). Axial non-contrast CT depicts bilateral symmetric calcifications in cerebellar foliae (thin black arrows) (A). Also note calcification in both dentate nuclei (white arrowheads) (A). There is extensive ...

Non-contrast CT is the most sensitive modality and there is lack of enhancement in regions of calcification.2 Prognosis is poor since the disease is progressive and there is no specific treatment. Antipsychotics may be used; but patients with Fahr's disease are more susceptible to adverse effects such as malignant neuroleptic syndrome.3

Learning points

  • Differentials for extensive calcification in basal ganglia, grey–white matter junction, dentate nuclei and thalami include Fahr's disease, hypoparathyroidism, pseudohypoparathyroidism and hyperparathyroidism. Other causes are senile calcification, calcification in HIV encephalopathy, Cockayne syndrome, and as sequelae to intrathecal chemotherapy and radiotherapy to brain.
  • Fahr's disease also known as striopallidodentate calcinosis, typically exhibits calcification of basal ganglia and extraganglionic sites, Parkinsonian-like features and schizophrenia-like symptoms.
  • There is no specific treatment for Fahr's disease. Antipsychotic medication has been tried but these patients are more prone to develop malignant neuroleptic syndrome with antipsychotic treatment.


Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.


1. Acou M, Vanslembrouck J, Deblaere K et al. Fahr disease. JBR-BTR 2008;91:19. [PubMed]
2. Hegde AN, Mohan S, Lath N et al. Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. Radiographics 2011;31:5–30 doi:10.1148/rg.311105041 [PubMed]
3. Ghormode D, Maheshwari U, Kate N et al. Fahr's disease and psychiatric syndromes: a case series. Ind Psychiatry J 2011;20:136–8 doi:10.4103/0972-6748.102527 [PMC free article] [PubMed]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group